Related Experiment Video
Updated: Mar 21, 2026

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance
Published on: February 14, 2025
Hypoxic tumor microenvironment: Opportunities to develop targeted therapies
1Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, United States.
Abstract:
In recent years, there has been great progress in the understanding of tumor biology and its surrounding microenvironment. Solid tumors create regions with low oxygen levels, generally termed as hypoxic regions. These hypoxic areas offer a tremendous opportunity to develop targeted therapies. Hypoxia is not a random by-product of the cellular milieu due to uncontrolled tumor growth; rather it is a constantly evolving participant in overall tumor growth and fate. This article reviews current trends and recent advances in drug therapies and delivery systems targeting hypoxia in the tumor microenvironment. In the first part, we give an account of important physicochemical changes and signaling pathways activated in the hypoxic microenvironment. This is then followed by various treatment strategies including hypoxia-sensitive signaling pathways and approaches to develop hypoxia-targeted drug delivery systems.
Insights
Targeting tumor hypoxia offers new therapeutic opportunities. This review covers advances in drug therapies and delivery systems for hypoxic tumor microenvironments.
Area of Science:
- Oncology
- Biochemistry
- Pharmacology
Background:
- Solid tumors develop hypoxic regions due to uncontrolled growth.
- Hypoxia significantly influences tumor progression and survival.
- These hypoxic areas present unique targets for cancer therapy.
Purpose of the Study:
- To review current trends and advances in drug therapies targeting tumor hypoxia.
- To explore novel drug delivery systems for hypoxic tumor microenvironments.
- To discuss physicochemical changes and signaling pathways in hypoxia.
Main Methods:
- Review of recent literature on hypoxia-targeted therapies.
- Analysis of signaling pathways activated in hypoxic conditions.
- Examination of drug delivery systems designed for hypoxic environments.
Main Results:
- Hypoxia involves specific physicochemical changes and signaling pathways.
- Various treatment strategies target hypoxia-sensitive pathways.
- Development of hypoxia-targeted drug delivery systems is advancing.
Conclusions:
- Understanding tumor hypoxia is crucial for developing effective cancer treatments.
- Targeting hypoxia offers a promising strategy for novel cancer therapies.
- Advances in drug delivery systems enhance the potential of hypoxia-targeted treatments.
More Related Videos
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
14:10Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Published on: December 15, 2010
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
The Tumor Microenvironment
The Tumor Microenvironment
Tumor Immunotherapy